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2 The authors contributed equally to this work.Biological activity of the neural cell adhesion molecule (NCAM) depends on both adhesion and acti-
vation of intra-cellular signaling. Based on in vitro experiments with truncated extra-cellular
domains, several models describing homophilic NCAM trans- and cis-interactions have been pro-
posed. However, cis-dimerization in living cells has not been shown directly and the role of the cyto-
plasmic part in NCAM dimerization is poorly understood. Here, we used the bioluminescence
resonance energy transfer (BRET2) technique to directly demonstrate that full-length NCAM cis-
homodimerizes in living cells. Based on BRET250 values we suggest that the intra-cellular part of
NCAM inhibits cis-dimerization, an effect mainly dependent on the palmitoylation sites.
Structured summary:
MINT-8071463: NCAM140 (uniprotkb:P13591-1) physically interacts (MI:0915) with NCAM140
(uniprotkb:P13591-1) by bioluminescence resonance energy transfer (MI:0012)
MINT-8071506: NCAM180 (genbank_protein_gi:119587605) physically interacts (MI:0915) with NCAM-
180 (genbank_protein_gi:119587605) by bioluminescence resonance energy transfer (MI:0012)
MINT-8071483: NCAM140 (uniprotkb:P13591-1) physically interacts (MI:0915) with NCAM140
(uniprotkb:P13591-1) by competition binding (MI:0405)
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The neural cell adhesion molecule (NCAM) is a cell surface gly-
coprotein belonging to the immunoglobulin (Ig) superfamily of cellchemical Societies. Published by E
energy transfer; CAM, cell
bronectin type 3; GFP, green
ol; ICD, intracellular domain;
cule; Rluc, Renilla luciferase;
ology Laboratory, Hagedorn
fte, Denmark.adhesion molecules (CAMs). NCAM is predominantly expressed in
the nervous system and regulates neuronal and glial development
and regeneration, synaptic plasticity, and learning [1–3]. These ef-
fects depend on NCAM-mediated cell adhesion and intracellular
signaling and involve multiple homo- and heterophilic interactions
[1,2,4–6].
NCAM exists in three major isoforms, resulting from alternative
splicing of a single gene, and include two transmembrane isoforms,
NCAM-140 and -180, with intracellular domains (ICDs) consisting
of 120 and 386 amino acids, respectively, and NCAM-120, lacking
an ICD and linked to the membrane by a glycosylphosphatidylinos-
itol (GPI) anchor. All three isoforms share the same extracellular
domain (ECD) comprising ﬁve Ig-like (Ig) modules and two mem-
brane-proximal ﬁbronectin type 3 (Fn3) modules [7,8].lsevier B.V. All rights reserved.
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and different Ig modules have been implicated in binding [6].
According to a recent model, NCAM is always present on the cell
surface as cis-dimers, formed by interactions between IgI and II
modules, and the trans-homophilic interactions of the NCAM cis-
dimers cause NCAM-mediated cell adhesion [6,9] (Fig. 1). However,
this model is based on the crystal structure of a truncated ECD, and
the precise role of cis-dimerization is still unknown because the
formation of cis-dimers has not been directly demonstrated in liv-
ing cells.
Additionally, the importance of the ICD for NCAM-140 and -180
cis-dimerization has not been investigated. Intracellular domains
may either enhance dimerization via putative dimerization sites
or constitute a steric hindrance inhibiting dimerization. Further-
more, the ICD has binding sites for several intracellular proteins
that may affect dimerization. Thus, NCAM interacts with, for exam-
ple, non-receptor tyrosine kinase Fyn via the receptor protein tyro-
sine phosphatase RPTPa, growth-associated protein 43, and
spectrin [4,10–14]. Such intracellular binding partners may affect
dimerization by localizing NCAM to distinct plasma membrane re-
gions. Furthermore, the ICD of NCAM contains a palmitoylation site
(PS) consisting of four cysteins, and palmitoylation of this site tar-
gets NCAM-140 and -180 to lipid rafts [4,15,16]. Whereas NCAM-
120 is almost exclusively present in rafts as a consequence of its
GPI anchor, NCAM-140 and -180 are found in both raft and non-
raft membrane fractions [8,17–21].
The present study addressed the question whether NCAM cis-
dimerizes in living cells and whether the ICDs of NCAM inﬂuence
this dimerization. This was investigated directly using the biolumi-
nescence resonance energy transfer2 (BRET2) technique. We report
that the interactions between NCAM ECDs are sufﬁcient to allow
cis-dimerization in living cells and that the ICD attenuates NCAM
dimerization mainly via palmitoylation sites.
2. Materials and methods
2.1. Expression vectors
cDNA fragments were synthesized by polymerase chain reac-
tion with MluI/SacII sites ﬂanking human NCAM-180 (residues
1-1119, NCBI accession code EAW67201) and the following
fragments of human NCAM-140 (Uniprot code:P13591-1):Fig. 1. Models of the NCAM homophilic adhesion complex. NCAMmolecules are shown a
two membrane-proximal Fn3 modules in green. The models are based on (A) cell and
magnetic resonance analysis and the crystal structure of the NCAM IgI–II fragment, andNCAM-140 (full length; residues 1–848), NCAM-PS-trunc (trun-
cated after intracellular PSs; residues 1–755), and NCAM-trunc
(truncated after the transmembrane domain [TMD]; residues 1–
737). The plasmids used as templates were described previously
[22,23]. The ampliﬁed cDNA fragments were subcloned into
pGFP2-N3 and pRluc-N3(h) (Perkin–Elmer). As a result of cloning,
the linker PRARDPPVAT from the multiple cloning site of the vec-
tors is present between NCAM fragments and GFP2/Rluc. Untagged
NCAM constructs were produced by mutagenesis introducing a
stop codon after the linker in the GFP2-tagged NCAM constructs.
All cDNA clones were veriﬁed by sequencing, and membranous
localization of all GFP2-fused constructs was shown by ﬂuores-
cence microscopy (Suppl. Fig. 1A–D).
To avoid interference between GFP2/Rluc moieties and the
extracellular dimerization of NCAM as well as the possible contri-
bution to a BRET2 signal of trans-dimerization, all constructs were
designed to have Rluc or GFP2 fused to the C-terminus of the NCAM
isoforms (Figs. 2B and 3C).
2.2. Cell culture and transfection
COS-7 cells were purchased from the American Type Culture
Collection and grown in Dulbecco’s modiﬁed Eagle’s medium
(DMEM) supplemented with glutamax, 10% fetal bovine serum,
penicillin-streptomycin, fungizone, and 1.5 g/l sodium bicarbonate
(all purchased from Invitrogen) in 5% CO2 at 37 C. For transient
transfection, COS-7 cells were seeded at a density of 3  106 cells
per T-80 ﬂask (Nunc). Transfections were performed the following
day using Lipofectamine™ 2000 (Invitrogen) or FuGENE 6 (Roche)
according to the manufacturers’ instructions. Cells were harvested
in 5 mM EDTA 48 h after transfection, washed twice in phosphate-
buffered saline (PBS; Invitrogen), and resuspended in Dulbecco’s
PBS supplemented with 1 g/l glucose (Invitrogen) to a density of
1  106 cells/ml.
2.3. BRET2 assay
The BRET2 technique is based on resonance energy transfer
between a light-emitting donor (Renilla luciferase [Rluc]) and a
ﬂuorescent acceptor (Green ﬂuorescence protein2 [GFP2]). The
technique allows the detection of physical interactions at distances
up to 100 Å between two proteins fused to Rluc and GFP2 moieties.ttached to the cell membranes of two opposing cells, with Ig modules in blue and the
microsphere aggregation experiments, (B) surface plasmon resonance and nuclear
(C and D) the crystal structure of the NCAM IgI–III fragment [6].
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Fig. 2. (A) Saturation BRET2 experiments showing cis-homodimerization of NCAM-trunc compared with a negative control (see Section 2). Data are pooled individual
readings in quadruplicate from at least three experiments. (B) Schematic structure of NCAM-trunc and negative control constructs used in the BRET2 experiments. (C)
Competition BRET2 assay showing that untagged NCAM-trunc competes with the tagged NCAM-trunc for binding in cis-dimer complexes. Data are expressed as the
average ± S.E.M. from pooled individual readings in quadruplicate from at least three experiments. ***P < 0.001, compared with no competition.
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tion describes a hyperbolic function when BRET2 values are de-
picted as a function of GFP2/Rluc ratios, whereas a non-speciﬁc
interaction elicits a linear relationship. The relative afﬁnities of
protein interactions are depicted as the GFP2/Rluc ratio yielding
50% of the maximal BRET2 signal (BRET250) [24,25].
The BRET2 assay was performed as described previously [26].
Brieﬂy, 180 ll of resuspended cells were distributed in 96-well
microplates in quadruplicate (white Optiplate; Packard BioSci-
ence). Microplates were shaken until the luminescence measure-
ments to maintain free-ﬂoating single cell suspensions. The Rluc
substrate DeepBlueC™ was injected at a ﬁnal concentration of
5 lM into each well, and readings were then collected 2 s after
each injection (Mithras LB 940 plate reader; Berthold Technolo-
gies). Signals at 395 nm (Rluc signal) and 515 nm (emission of
light from excited GFP2) were measured sequentially, and 515/
395 ratios (BRET2 signal) were calculated and expressed as
milliBRET2.The expression of GFP2-tagged constructs in cells from the same
transfections as those used for the luminescence measurements
was measured in black microplates with a clear bottom in quadru-
plicate (ViewPlate; Packard BioScience) at a density of 5  104
cells/well. After 1 h incubation in darkness, ﬂuorescence was mea-
sured using the NovoStar microplate reader (BMG LabTech), with
an excitation line at 485 nm and an emission ﬁlter at 520 nm.
Background values for ﬂuorescence and BRET2 measurements ob-
tained with untransfected cells were subtracted.
For BRET saturation, cells were transfected with a constant
amount of DNA encoding the Rluc variant and increasing amounts
of DNA encoding the GFP2 variant. Values along the x-axis in
Figs. 2A and 3A are ratios between values from ﬂuorescence and
luminescence (395 nm) measurements, and lg-transformed
BRET250 values were used for afﬁnity comparisons (Fig. 3B). The
pcDNA3.1(+) plasmid (Invitrogen) was added to transfections to
ensure a constant total amount of DNA. As a negative control, a
membrane-tagged GFP2 construct (NC) was co-transfected with
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Fig. 3. (A) Saturation BRET2 experiments showing cis-dimerization of NCAM-trunc, NCAM-140, NCAM-180, NCAM-trunc/140, and NCAM-PS-trunc. The BRET curve for NCAM-
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GFP2 construct encodes a 14 amino acid sequence derived from
p59Fyn containing myristoylation and palmitoylation sites fused
to the N-terminus of GFP2 causing membrane localization of GFP2
[27]. Membranous localization of the NC-GFP2-fused constructs
was veriﬁed by ﬂuorescence microscopy (Suppl. Fig. 1E).
The efﬁciency of energy transfer in BRET2 experiments depends
on the orientation between the two BRET2 partners. The speciﬁc
orientation between the BRET donor and acceptor can result in
highly efﬁcient energy transfer, which can be seen as a decrease
in the Rluc signal upon increasing amounts of GFP2. This can affect
the accuracy of the BRET250 value estimation. In all of our experi-
ments, the signal from Rluc did not decrease in the presence of
increasing amounts of GFP2, indicating low efﬁciency and similar
orientations between the two BRET partners for all BRET pairs.For example, the Rluc signals in the absence or maximal concentra-
tion of GFP2 were 100/90.63 for NCAM-trunc-Rluc/NC-GFP2, 100/
100.52 for NCAM-trunc-Rluc/NCAM-trunc-GFP2, 100/85.49 for
NCAM-PS-trunc-Rluc/NCAM-PS-trunc-GFP2, 100/79.54 for NCAM-
140-Rluc/NCAM-140-GFP2, 100/101.70 for NCAM-180-Rluc/
NCAM-180-GFP2, and 100/81.89 for NCAM-trunc-Rluc/NCAM-
140-GFP2, respectively.
For BRET2 competition, cells were transfected with a constant
amount of plasmids encoding Rluc- and GFP2-tagged receptors at
a 1:1 cDNA ratio (NCAM-trunc, 2 lg; NCAM-140, 4 lg) and
increasing amounts of the untagged receptor. The pcDNA3.1(+)
plasmid (Invitrogen) was added to transfections to ensure a con-
stant total amount of DNA.
Statistical signiﬁcance was assessed using one-way analysis of
variance (ANOVA; SAS 9.1).
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3.1. The ECD of NCAM is sufﬁcient to allow cis-dimerization in living
cells
The ECD of NCAM is generally believed to be a prerequisite for
NCAM cis-dimerization [6]. To demonstrate this directly, the ability
of a truncated NCAM-140 devoid of an ICD (NCAM-trunc, Fig. 2B)
to cis-dimerize was investigated. A hyperbolic relationship
between the BRET2 signal and the GFP2/Rluc ratio for the
NCAM-trunc, but not control, construct was found (Fig. 2A),
demonstrating that the ECD of NCAM is indeed sufﬁcient to allow
cis-homodimerization in living cells. As a further negative control
construct, we synthesized constructs encoding the NCAM signal
peptide and transmembranous domain with or without palmitoy-
lation sites but devoid of extracellular Ig, Fn3 and cytoplasmic do-
mains. These constructs, however, were not localized to the plasma
membrane (Suppl. Fig. 2) and could therefore not be included as
negative controls. This suggests a hitherto unknown role of a por-
tion of the NCAM ECD for stable insertion in the membrane, e.g.,
through binding to an unknown protein in the membrane. The ab-
sence of ECD may also affect the signal peptide processing.
Although membranous localization of NCAM-GFP constructs is
shown (Suppl. Fig. 1), a contribution of mislocalized protein to
the BRET signal cannot formally be excluded. To conﬁrm the exis-
tence of cis-homo-dimers, we performed a competition assay. As
shown in Fig. 2C, the BRET2 signal decreased with increasing
amounts of competitor (untagged NCAM-trunc), validating the
existence of NCAM-trunc cis-dimers in living cells.3.2. The intracellular domains of NCAM-140 and -180 attenuate
cis-dimerization
To investigate whether the presence of ICDs affects NCAM
dimerization, we synthesized constructs encoding full-length
NCAM-140 fused to GFP2 and Rluc (Fig. 3). As shown in Fig. 3A
and B, NCAM-140 is able to cis-dimerize; however, the BRET250 va-
lue increased in the presence of the NCAM-140 ICD, suggesting
attenuated cis-dimerization. Similar to NCAM-trunc, NCAM-140
cis-dimerization was veriﬁed by a competition BRET2 assay, sup-
porting the speciﬁcity of the dimerization (Suppl. Fig. 3). To inves-
tigate whether the increased BRET250 value was dependent on the
length/composition of the ICD, we investigated the ability of full-
length NCAM-180 GFP2 and Rluc fusion proteins to cis-dimerize
(Fig. 3C). Similar to NCAM-140, NCAM-180 was found to cis-dimer-
ize, and the presence of the NCAM-180 ICD led to an increased
BRET250 value compared with NCAM-trunc, suggesting that
cis-dimerization was attenuated (Fig. 3A and B). The BRET250 val-
ues of full-length NCAM-140 and -180 homodimerizations did
not differ (Fig. 3B), indicating no major effect of the extra domain
that is present in the ICD of NCAM-180 compared with NCAM-
140 on homodimerization efﬁciency. Because of the low maximal
BRET values, we were not able to evaluate the NCAM-180 construct
in the BRET2 competition assay.3.3. The inhibitory effect of the intracellular domain on NCAM cis-
dimerization is independent of the interaction between intracellular
domains
We next investigated whether the observed inhibitory effect of
the ICD on NCAM dimerization was a consequence of the interac-
tion between ICDs by examining cis-dimerization of NCAM-trunc
and NCAM-140 (Fig. 3C). As shown in Fig. 3A and B, cis-heterodi-
merization was observed, with BRET250 values similar to those of
NCAM-140 and -180 cis-homodimerization. This suggests thatthe inhibitory effect of the NCAM ICD on cis-homodimerization is
independent of the interactions between the ICDs.
3.4. The presence of palmitoylation sites in the intracellular domain is
sufﬁcient to mediate attenuated dimerization
Because the inhibitory effect of ICDs on cis-dimerization was
independent of direct interactions, we examined whether the pres-
ence of PSs in the ICD could mediate attenuated dimerization. We
synthesized a construct to include a PS but lacking the remainder
of the ICD (NCAM-PS-trunc, Fig. 3C) and examined the effect on
cis-dimerization. As seen in Fig. 3A and B, the BRET250 value of this
construct was higher compared with not only NCAM-trunc but also
NCAM-140, NCM-180, and NCAM-trunc/NCAM-140 cis-dimers.
This suggests that the presence of the PS alone is sufﬁcient to inhi-
bit dimerization, and the ICD C-terminal to the PS may partially
counteract the inhibitory effect of the PS on dimerization.4. Discussion
The role of cis-dimerization in NCAM dimerization is debated.
Here, we directly demonstrate using saturation and competition
BRET2 that NCAM does indeed cis-dimerize in living cells. Further-
more, the BRET250 values suggested that the presence of the intra-
cellular PS attenuated dimerization, and this attenuation is partly
counteracted by the presence of the ICD C-terminal to the PS.
These results are consistent with a recent model based on the
crystal structure of the ﬁrst three Ig modules (Fig. 1C and D) [9].
In this model, the role of cis-dimerization is a prerequisite for
NCAM clustering on the cell surface, which in turn results in
cell–cell adhesion via trans-interactions between NCAM clusters.
By ensuring that the cells were in suspension and present as single
cells until the measurements were taken, we minimized the possi-
bility that the observed cis-dimers were secondary to trans-
interaction.
Earlier studies investigating the molecular mechanisms of
NCAM dimerization have been performed exclusively on NCAM
ECDs. However, the ICDs may affect dimerization in several ways
as described above. Based on BRET250 values, the present data
show that the presence of the PS in the NCAM ICD attenuates
dimerization. Furthermore, the BRET250 values for the NCAM-
140 and -180 constructs were lower than the BRET250 value for
the NCAM-PS-trunc construct, suggesting that the ICD C-terminal
to the PS counteracts the inhibitory effect of palmitoylation. This
effect is most likely not caused by interactions between the two
ICDs because NCAM-trunc/NCAM-140 dimerizes with a BRET250
similar to the corresponding values for the NCAM-140 and -180
homodimers. Further studies are needed to unravel the exact
molecular mechanisms underlying the inhibitory effect of palmi-
toylation and the counteracting effects of the ICD C-terminal to
the PS on NCAM cis-dimerization.
In this study, we did not investigate the ability of native GPI-an-
chored NCAM-120 to cis-dimerize because fusing GFP2/Rluc moie-
ties to a GPI anchor is not possible. Because NCAM-120 is targeted
to lipid rafts independently of palmitoylation, examination of GPI-
anchored NCAM-120 cis-dimerization afﬁnity would clarify
whether the inhibitory effects of palmitoylation are consequences
of lipid raft associations or steric effects.
The BRET2 saturation experiments conducted in the present
study allow quantitative interpretation of the BRET2 signal com-
pared with basic BRET2 experiments [25,28,29]. The BRET2 satura-
tion experiments have been successfully used previously to study
ligand-induced conformational changes between preassociated
BRET2 donor and acceptor fusion proteins [28,29], to compare the
relative afﬁnities of various pairs of interacting proteins [25], as
N. Kulahin et al. / FEBS Letters 585 (2011) 58–64 63to estimate ratios between dimeric and monomeric fractions of the
two BRET2 partners [25,28]. In the BRET2 saturation experiments,
upon an increase in the concentration of a BRET2 acceptor, the
BRET2 signal increases as a hyperbolic function, reaching an
asymptote (maximal BRET2 signal) that corresponds to the satura-
tion of all BRET2 donor molecules by acceptor molecules. Assuming
that the association of interacting proteins fused to the BRET2 do-
nor and the BRET2 acceptor is random, the relative afﬁnity of the
interaction can be estimated by half-maximal BRET2 (BRET250)
[25].
However, several aspects of conducting the BRET2 saturation
experiments must be considered to correctly interpret the present
results. Thus, saturation of the curve is important because the
accuracy of the determination of the BRET250 value depends on
the precision of the determination of the maximal BRET2 value.
The BRET2 signal in the BRET2 saturation experiments depends
on the concentrations of the BRET2 donor and acceptor molecules
and on the efﬁciency of energy transfer between the two mole-
cules. The efﬁciency of energy transfer depends on the spectral
overlap between the donor emission spectrum and the acceptor
excitation spectrum and on the distance and orientation between
the two molecules. Although the spectral overlap was the same
for all NCAM BRET2 constructs, a change in the distance and orien-
tation between the two BRET2 partners could result in different
maximal BRET2 and BRET250 values. A larger distance between
the two BRET2 partners will result in a lower maximal BRET2 signal.
A higher efﬁciency of energy transfer will result in a ﬂatter satura-
tion curve (higher BRET250 values) [30]. Moreover, a higher num-
ber of molecules participating in binding (oligomerization vs.
dimerization) will result in steeper saturation curves with lower
BRET250 values [30].
Although the distance between the two BRET2 partners primar-
ily affects the maximal BRET2 signal, the orientation between the
two molecules affects both maximal BRET2 and BRET250 values.
To use BRET250 values to compare afﬁnities of interactions be-
tween different NCAM constructs, we controlled the efﬁciency of
energy transfer for all of our BRET2 pairs. In all of our experiments,
we did not see a signiﬁcant decrease in the signal from RLuc upon
an increase in the amount of GFP2 protein, indicating low efﬁciency
and similar orientations between the two BRET2 partners. Several
models suggest both dimerization and oligomerization of NCAM.
Oligomerization of NCAM would result in a steeper saturation
curve in BRET2 experiments with a lower BRET250 value compared
with dimerization. However, all NCAM constructs used in our
study had the same extracellular part, indicating that either all
NCAM constructs dimerized or that all NCAM constructs
oligomerized.
Although the possibility that the BRET250 values for different
NCAM BRET2 pairs are affected by additional parameters cannot
be excluded, we believe that BRET250 values could be used to com-
pare the afﬁnities of the interactions between various NCAM
isoforms.
The BRET2 signal depends on the distance between GFP2 and
Rluc moieties, and we expected that the maximum BRET2 signals
would differ between the constructs because of differences in the
length and ﬂexibility of the ICDs of the proteins. As shown in
Fig. 3A, the saturation BRET2 signal for NCAM-trunc  NCAM-PS-
trunc > NCAM-140 > NCAM-180 as predicted. Also as predicted,
the maximum BRET2 signal for the NCAM-140/NCAM-trunc dimer
was lower compared with the NCAM-trunc homodimer because of
the distance and ﬂexibility introduced by the NCAM-140 ICD.
Several studies have previously demonstrated an NCAM high-
afﬁnity interaction between the ﬁrst two N-terminal Ig modules
[9,31,32]. A steep BRET saturation curve for the NCAM-trunc con-
struct consisting of the ECD, transmembrane part, and Rluc or
GFP2 apparently reﬂects this interaction (dimerization). None ofour experiments indicated that the PS affects the efﬁciency of en-
ergy transfer. Thus, we presume that we observe high-afﬁnity
dimerization of NCAM-trunc constructs, and this interaction is af-
fected by the presence of the ICD and PS.
In conclusion, we report that the ECD of NCAM is sufﬁcient to
allow cis-dimerization in living cells and that palmitoylation of
the ICD attenuates NCAM homophilic interactions. This attenua-
tion is partially counteracted by the presence of the ICD C-terminal
to the PS. We suggest that palmitoylation of NCAM is a ﬁne-tuning
mechanism for NCAM-mediated cell adhesion and synaptic
plasticity.Acknowledgements
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